LAKE FOREST, Calif., April 15, 2019 (GLOBE NEWSWIRE) -- InMode Ltd., a leading global provider of innovative, energy-based, minimally invasive solutions, introduces AccuTite, the smallest Radio-Frequency Assisted Lipolysis (RFAL) device for the treatment of face and body areas that require precise heating and pinpoint accuracy.
AccuTite, the newest addition to InMode’s RFAL technologies, aims to revolutionize minimally invasive in-office procedures by offering a solution for tissue remodeling without excisional surgery. Responding to the growing demand of patients, AccuTite, with its sub-millimeter cannula, enables treatment of delicate areas with pinpoint accuracy, with little or no visible scarring, and with minimum downtime.
Using AccuTite, in less than 15 minutes, physicians can now achieve exceptional results under local anesthesia. It has been shown that the effects can be seen immediately, with continuing improvements for several weeks following treatment. Studies have demonstrated that improvements achieved with treatment have been maintained for up to 12 months post-RFAL procedure.
Moshe Mizrahy, co-founder and Chief Executive Officer of InMode, commented, “We are excited to offer AccuTite, the newest of our breakthrough radio frequency technologies to add to our growing product portfolio. We continue to work together with physicians around the world to develop innovative solutions to meet the growing need for minimally invasive and non-invasive aesthetic and wellness solutions.”
“InMode is setting the standard for the next generation of RF developments resulting in more options with higher revenue for physicians, and less time required in the operating room,” says President of North America, Shakil Lakhani. “We continue to provide the latest in medical advancements with our strong attention to top-of-the line quality and outcomes.”
About InMode
InMode Ltd. is a leading global provider of innovative medical technologies. InMode develops, manufacturers, and markets devices harnessing novel radio-frequency (RF) based devices that strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology and ophthalmology. For additional information, visit www.inmodemd.com.
Press Contact:
Behrman Communications
Amanda Reinstein
areinstein@behrmanpr.com